Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the diseaseGeorg Jeryczynski, Heinz Gisslinger, Alexander Nader et al.|American Journal of Hematology|2017Cited by 66
Impact of white blood cell counts at diagnosis and during follow‐up in patients with essential thrombocythaemia and prefibrotic primary myelofibrosisVeronika Buxhofer‐Ausch, Heinz Gisslinger, Bettina Gisslinger et al.|British Journal of Haematology|2016Cited by 20
Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical dataMartin Schalling, Heinz Gisslinger, Andreas Gleiß et al.|Blood Cancer Journal|2017Cited by 20
Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancerVeronika Buxhofer‐Ausch, Theresia Thalhammer, Orsolya Német et al.|Oncology Letters|2020Cited by 8
Abundance of the Organic Anion-transporting Polypeptide OATP4A1 in Early-Stage Colorectal Cancer Patients: Association With Disease RelapseVeronika Buxhofer‐Ausch, Theresia Thalhammer, Maidah Sheikh et al.|Applied immunohistochemistry & molecular morphology|2018Cited by 5